Nexgel Inc (NXGL) - Total Liabilities
Based on the latest financial reports, Nexgel Inc (NXGL) has total liabilities worth $7.12 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Nexgel Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Nexgel Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Nexgel Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Nexgel Inc balance sheet assets.
Nexgel Inc Competitors by Total Liabilities
The table below lists competitors of Nexgel Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tristel
LSE:TSTL
|
UK | GBX11.88 Million |
|
Vp plc
LSE:VP
|
UK | GBX334.73 Million |
|
Baronsmead Second Venture Trust Plc
LSE:BMD
|
UK | GBX1.28 Million |
|
MOBA Network publ AB
ST:MOBA
|
Sweden | Skr357.78 Million |
|
Sodas Sodyum Sanayi AS
IS:SODSN
|
Turkey | TL9.87 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Nexgel Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Nexgel Inc's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.78 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nexgel Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nexgel Inc (2016–2025)
The table below shows the annual total liabilities of Nexgel Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $5.57 Million | +13.60% |
| 2024-12-31 | $4.90 Million | +2.38% |
| 2023-12-31 | $4.79 Million | +76.07% |
| 2022-12-31 | $2.72 Million | -44.47% |
| 2021-12-31 | $4.90 Million | +124.06% |
| 2020-12-31 | $2.19 Million | +44.77% |
| 2019-12-31 | $1.51 Million | +229.69% |
| 2018-12-31 | $458.00K | +70.26% |
| 2017-12-31 | $269.00K | -42.40% |
| 2016-12-31 | $467.00K | -- |
About Nexgel Inc
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It a… Read more